Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 306

1.

Second-line chemotherapy for advanced hormone-refractory prostate cancer.

Garmey EG, Sartor O, Halabi S, Vogelzang NJ.

Clin Adv Hematol Oncol. 2008 Feb;6(2):118-22, 127-32. Review.

PMID:
18347563
3.

Treatment options in hormone-refractory metastatic prostate carcinoma.

Fusi A, Procopio G, Della Torre S, Ricotta R, Bianchini G, Salvioni R, Ferrari L, Martinetti A, Savelli G, Villa S, Bajetta E.

Tumori. 2004 Nov-Dec;90(6):535-46. Review.

PMID:
15762353
5.

Hormone refractory prostate cancer (HRPC): present and future approaches of therapy.

Di Lorenzo G, De Placido S.

Int J Immunopathol Pharmacol. 2006 Jan-Mar;19(1):11-34. Review.

PMID:
16569343
6.

Treatment options in hormone-refractory prostate cancer: current and future approaches.

Harris KA, Reese DM.

Drugs. 2001;61(15):2177-92. Review.

PMID:
11772129
7.

State-of-the-art treatment of metastatic hormone-refractory prostate cancer.

Goodin S, Rao KV, DiPaola RS.

Oncologist. 2002;7(4):360-70. Review.

8.

Satraplatin: BMS 182751, BMY 45594, JM 216.

[No authors listed]

Drugs R D. 2007;8(2):125-32. Review.

PMID:
17324011
9.

Chemotherapy for hormone-refractory prostate cancer.

Shelley M, Harrison C, Coles B, Staffurth J, Wilt TJ, Mason MD.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005247. Review.

PMID:
17054249
10.

Management of patients with hormone refractory prostate cancer.

Muthuramalingam SR, Patel K, Protheroe A.

Clin Oncol (R Coll Radiol). 2004 Dec;16(8):505-16. Review.

PMID:
15630842
11.

Achieving treatment goals for hormone-refractory prostate cancer with chemotherapy.

Berry W, Eisenberger M.

Oncologist. 2005;10 Suppl 3:30-9. Review.

12.

Chemotherapy in advanced prostate cancer.

Beedassy A, Cardi G.

Semin Oncol. 1999 Aug;26(4):428-38. Review.

PMID:
10482185
13.

New standards in the chemotherapy of metastatic hormone-refractory prostate cancer.

Sava T, Basso U, Porcaro A, Cetto GL.

Expert Rev Anticancer Ther. 2005 Feb;5(1):53-62. Review.

PMID:
15757438
14.

Chemotherapy for advanced prostate cancer: results of new clinical trials and future studies.

Armstrong AJ, Carducci MA.

Curr Oncol Rep. 2005 May;7(3):220-7. Review.

PMID:
15847714
15.

Chemotherapy for advanced hormone refractory prostate cancer.

Petrylak DP.

Urology. 1999 Dec;54(6A Suppl):30-5. Review.

PMID:
10606282
16.
17.

Treatment of hormone refractory prostate cancer.

Knox JJ, Moore MJ.

Semin Urol Oncol. 2001 Aug;19(3):202-11. Review.

PMID:
11561988
18.

Actual chemotherapeutical possibilities in hormone-refractory prostate cancer (HRPC) patients.

Prezioso D, Galasso R, Di Martino M, Iapicca G, Annunziata E, Iacono F.

Anticancer Res. 2007 Mar-Apr;27(2):1095-104. Review.

19.

Chemotherapy for hormone-refractory prostate cancer: now it's a question of "when?".

Ryan CJ, Eisenberger M.

J Clin Oncol. 2005 Nov 10;23(32):8242-6. Review.

PMID:
16278479
20.

The 5th Conference on Asian Trends in Prostate Cancer Hormone Therapy.

Akaza H, Moore MA, Chang SJ, Cheng C, Choi HY, Esuvaranathan K, Hinotsu S, Hong SJ, Kim CS, Kim WJ, Murai M, Naito S, Soebadi D, Song JM, Umbas R, Usami M, Xia S, Yang CR.

Asian Pac J Cancer Prev. 2007 Jan-Mar;8(1):3-12.

Items per page

Supplemental Content

Support Center